The Consortium includes five Research Centers, a Data Coordinating Center, National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) program staff, and other collaborators and research groups studying the genomics of rare diseases who wish to become partner members.
Collaboration is a primary theme and will be part of our work in many ways including data sharing within both the GREGoR Consortium and the broader community; Working Groups including members from each Research Center; and exploring innovative partnerships. Outreach, education and advocacy are critical as we learn new ways to solve Mendelian diseases and develop new tools and creative methods that we can share with the broader scientific community.
How we are funded - NHGRI
The GREGoR Consortium is funded by the National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH). Established in 1989, NHGRI collaborates with scientific and medical communities to catalyze genomic breakthroughs and supports the robust study and treatment of specific diseases with our colleagues at NIH. In this uniquely collaborative organization, everyone is focused on contributing to high-impact research and helping to apply new discoveries to the study of human health.
Lisa H. Chadwick, PhD, Program Director, Division of Genome Sciences
Chris Wellington, Program Director, Division of Genome Sciences